Penny Ward MBBS, FFPM - Chief Medical Officer

Penny has over two decades of experience in clinical development and medical affairs, having held senior management/therapeutic area head roles in Pharmacia and Upjohn, Roche, GSK and UCB. Previously, she was CMO at Novimmune, Glenmark and Topivert, and is the owner and director of private consulting company, PWG Consulting (Biopharma) Ltd. offering Chief Medical Officer services to Karus Therapeutics (since 2013), Blue Earth Diagnostics (2014–2017), and Achilles Therapeutics. She is also the medical consultant for Syncona Investment Management Ltd. Penny’s work has enabled the approval of multiple products, including small molecules and biologics, for the treatment of infectious diseases, osteoporosis, cancer and autoimmune disorders in the US, EU and Japan, switches from prescription to non prescription status, and the development and approval of diagnostics, including the recent US/EU approval of Axumin.